PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS: $253M Department of Health and Human Services Grant
Summary
The Pennsylvania Department of Drug and Alcohol Programs received a $253M grant from SAMHSA for the State Opioid Response program, continuing federal efforts to combat opioid use disorder. While the recipient is a state agency, this funding flows to healthcare providers and harm reduction services across Pennsylvania, benefiting the broader healthcare sector.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $253M grant to Pennsylvania is part of the federal State Opioid Response program, a multi-year initiative to combat the opioid crisis.
- 2.While no public company directly benefits, the funding supports healthcare infrastructure for addiction treatment, potentially increasing demand for MOUD medications and harm reduction products.
- 3.Investors should monitor state-level opioid spending as a signal of sustained federal commitment to behavioral health funding.
Market Implications
The grant does not directly impact any publicly-traded company's revenue, but it underscores the continued government focus on the opioid crisis. Companies in the pharmaceutical sector that produce medications for opioid use disorder (e.g., buprenorphine) or naloxone may experience steady demand, but this contract alone is not a catalyst. The broader trend of increased SAMHSA grants supports the healthcare services sector.
Full Analysis
The Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded a $253 million project grant to the Pennsylvania Department of Drug and Alcohol Programs for the FFY 2024 State Opioid Response (SOR) grant. This award supports a comprehensive strategy to increase access to treatment, medication for opioid use disorder (MOUD), naloxone distribution, prevention, and recovery support services over three years (2024-2027). The recipient is a state government entity, not a publicly-traded company, so there is no direct stock impact from the contract itself. However, the funding will flow to various healthcare providers, non-profits, and community organizations that deliver these services. Companies in the addiction treatment space, such as those providing MOUD medications (e.g., buprenorphine, naltrexone) or harm reduction supplies (e.g., naloxone), could see indirect benefits from increased demand. The grant also includes public awareness campaigns and stigma reduction efforts, which may drive broader awareness and utilization of treatment services. No related legislation in the provided bill signals directly connects to this specific opioid response grant, although broader healthcare policy tailwinds exist.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS
Award Amount
$253,166,031
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →